Jennison Associates’s NovoCure NVCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-29,010
Closed -$516K 625
2025
Q2
$516K Sell
29,010
-3,169
-10% -$55.2K ﹤0.01% 540
2025
Q1
$573K Buy
+32,179
New +$731K ﹤0.01% 539
2020
Q2
Sell
-13,201
Closed -$889K 679
2020
Q1
$889K Sell
13,201
-179
-1% -$14.1K ﹤0.01% 504
2019
Q4
$1.13M Sell
13,380
-2,754
-17% -$222K ﹤0.01% 515
2019
Q3
$1.21M Buy
16,134
+102
+0.6% +$8.16K ﹤0.01% 526
2019
Q2
$1.01M Buy
16,032
+1,940
+14% +$98.3K ﹤0.01% 557
2019
Q1
$679K Buy
+14,092
New +$678K ﹤0.01% 588

Other funds holding NVCR